EREG and colorectal cancer: We found that TSGs (e.g., DKK1 and GAS5) in colorectal cancer with hypermethylated promotors were re-activated and two oncogenes (i.e., EREG and MALAT1) were down-regulated upon 5-AZA-CdR treatment.